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EDNA encodlng human PACAP prccunor wds expressed In non-ncurocndocrmc Chmsbc hamster ovary cellb, CHO-K 1. The cells were lransfcclcd 
with cxprcbsion vector (pTS705) contdmmg the human PACAP cDNA by clcctroporatlon A cell lint which produced more lhdn 80 @ml of 
ImmunorcactIvc PACAP (tr-PACAP) into the condltloned mcchum wds catabhbhcd RP-HPLC andlyblb ofcullurc medium orthIs csldblishcd cell 
hnc exhlbltcd the prcbcnce of 1v.o 1ype3 of PACAP. I c. PACAP and PACAP AI the bilmc lmic. 11 wds ~Iw rcvc&d lhdl ~mmunorc~clivc 
PACAP-reIdted pcptldc (lr-PRP) was sccrctcd mlo the cultured mcdlum The Ir-PACAPS were confirmed to hdvc blologlwl dcllvilm such ds 
induction of CAMP and neurllc outgrowth In rdt ph&xhromocytomd PCl2h ccll~ 
Human PACAP, PRP. Gcnc cxpresslon sybtcm (CHO-Kl), PCl2h, Ncuritc extension, CAMP dccumulatlon 
1 INTRODUCTION 
A novel neuropeptide with 38 amino acid residues 
and its shorter form (the N-terminal 27 residues), which 
stimulate adenylatc cyclase in a rat anterior pltultary 
cell culture, has been isolated and purified by Mryata et 
al. [I ,2]. These peptides named PACAP and 
PACAP have amidatcd C-termini. The N-termmal 
amino acid sequence of PACAP shows srmllarlty to 
vasoactive intestinal polyprptide (VIP); however, ade- 
nylate cyclase-stimulating activity of PACAP In cul- 
tured rat pituitary cells IS at least 1,000-times more than 
that of VIP [l]. In addition, the rat pheochromocytoma 
PCI 211 responds to PACAP by the extension of neurlteb 
and the secretion of CAMP [3]. 
Recently we have cloned and determined the nu- 
cleotlde sequence of cDNAs ecoding the PACAP prc- 
cursor from ovine hypothalamus, human testis and rat 
bram [4-61. The mature form of PACAP was found 
to be identical in these animals. An ammo acid sequence 
which has homology to peptide histidine methlonmc 
(PHM) and growth hormone-releasing hormone 
h!hwrutrorr~ PACAP, pituitary ddCnyldlC cyclasc activalmg poly- 
pcpttdc, PRP, PACAP-related peptlde; lr-PACAP, immunorcactlve 
PACAP. FBS, rctal bovme serum, HRP, horseradIsh pcroxrdasc. EIA, 
enzyme Immunoassay, FITC, fluoresccm Isothmcyanatc, PBS, phos- 
phate-buflcrcd saline, HBSS, Hanks’ bnlanccd salt bolutlon. TFA, 
tr~fluoroacctlc dad, RP-HPLC, rcversc-phase high pcrformunce hquld 
chromatography 
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(GRH) was ldentlfied In the PACAP precursor protein 
and named PACAP-related peptide (PRP) [6]. To de- 
cipher processmg and secretion of PACAP and PRP, we 
attempted to express the human PACAP cDNA in cul- 
tured mammdhan cells. 
The present report deals with the successful expres- 
slon of cDNA encodmg the human prepro-PACAP 
m non-ncuroendocrinc Chinese hamster ovary cells 
CHO-K I The transfccted CHO-KI cells produced 
more than SO ng/ml of immunoreactive PACAP lir- 
PAC4P) which exhibited biological activities in PC12h 
cells slmllar to chemically synthesized PACAPs. Partial 
charactcnzatlon of PACAP precursor protein from the 
transformed cells and secreted form of PRP are also 
reported. 
2. MATERIALS AND METHODS 
Rcstrlctlon enzymes, T4 DNA hgase dnd ldrgc frdgmcnl or E co/f 
DNA polymcrd* I (Klcnow frdgacntj were purchased from Takdra 
Shuzo Co (Kyc:o) An EcoRI I4 kb fragment from pldsmld 
pHT38PS [4] contdmmg the cnurc coding regon of human prepro- 
PACAP Wd3 Inscrtcd into 111~ Bg/lI sltc Iowtcd downstream of SV40 
early promoter of pTl3SS I lo obldin pTS705 The dcr,uls orconslruc- 
tton of pTS705 arc summdrlLed In Fig I 
2 2 Cell ~ullurc und frumjiiclron of LAVA5 
CHO-K I cells (ICN Blomcdlmls Inc. Cosk~ MAP. CA) were grown 
In Hflm’s FIZ mcdtum (NISSUI Sclyaku, Tokyo) with 10% kvlnc 
serum (FBS, from M.A Btoproductb. MD). pcnicllhn G (Ban-yu 
Sclyaku, Tokyo) and streptomycm (MelJi Sclka. Tokyo) under 5% 
CO/9S% air dt 37*C 
PC12h cells, kindly provIderI by Dr H Haianaka (Inslllutc for 
Protcm Rescilrch. Osaka Umvcrsrty). wcrc grown in Dulbecco’s 
modified Ea$,?s mcdlum (DMEM, NISSUI Sclyaku) with 10% 
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newborn calf strum (Mitsubishi Kasci Corp., Tokyo), penicillin G and 
streptomycin. 
Translbrmation of CHO-K I wlls WYS performed by electroporation 
method [7]. CHO-K1 cells were co-transfccted with pTS705 and 
pSVZneo (Pharmacia) in mannitol bulTer (025 M mannitol, 0.1 mM 
CaClz. 0. I mM MgC12. 0.2 mM Tris-HCI. pH 7.4) by three rectangle 
pulses of 3.0 kV/cm, 50 psec using Shimadzu Somatic Hybridizer 
SSH-I (Shimadzu, Kyoto). Tronslbrmed cells were selected with 500 
pdrnl of (2418 (GIBCO, Life Technologies Inc.) [S]. and cloned by 
colony formation and limiting dilufion method. 
ea 
PACAP38. PACAP and PRP (Scr”?-Asp”“) were chemically syn- 
thesizcd by an automatic synthesiirer (ASI model 430A, Applied Bio- 
systems Inc., Foster City. CA) in our laboratory. 
Immunoreactivity of PACAP and PRP was tested by the compeli- 
tive enzyme immunoassay method [9]. Briefly, 50 yl of samples and 
50 yl of l-l.3 x IO’ diluted rabbit anti-PACAP antiserum [lo] or 
l-1.25 x IO’ diluted rabbit anti-PRP antiserum were mixed on an 
1.4kb LI 
I 
‘1’4 DNA polymerase 
Bgl II linker ligation 
d(pC.A-G-A-T-C-T-G) 
Ugl II digestion 
early promoter 
Fig, 1. Construction of human PACAP expression vector pTS705. 
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anti-rabbit IgG-coated 96.well plate. After incubation for 1 h at room 
temperature, 50~1 of I:100 diluted PACAP38-horseradish pcroxidase 
(HRP) conjugale or 1:2,OCtO diluted PRP-HRP conjugate were added. 
These conjugates were made according to the methods of lshikawa et 
al, [I I], AtIer an overnight incubation at 4OC, the plate was washed 
with phosphate-buflered saline (PBS) and then 100 ~1 of HRP sub- 
strate solution (TMB Microwell Peroxidase Substrate System, Kir- 
kegaard & Perry Labs. Inc., MD) was added to each well. The plate 
was incubated for 20 min at room temperature and IO0 ~1 of 1 M 
HaPO., was added for terminating the reaction. Optical density ofeach 
well wss measured at 450 nm. 
Total RNA extraction, purification of poly(A)’ RNA, size 
fractionation of poly(A)+ RNA, transfer to nylon membrane filter 
(Biodyne A. Pall Biosupport. Glen Cove, NY) [12] and hybridization 
were done as previously dticribed [S], The probe used was [“PI-labeled 
I .4 kb EcuRl fragment of pHT38P8 which encodes PACAP prc- 
cursor proiein. The specific activity of the probe was 4 x IO” cpm&g 
DNA. 
CHO-K I cells and their transformants cultured on Slide Chambers 
(Nunc) were Axed with 3% paraformaldehyde, made permeable with 
0. I % Triton X-l 00 and blocked with 2% bovine serum albumin. These 
were treated with 1: 1,000 diluted mouse anti-PACAP monoclonal 
antibody PA-IN (Suzuki, N. et al., in pnparation)and 1:2,OOOdiluted 
fluorescein isothiocyanate (FlTC)-conjugated rabbit anti-mouse IgG 
antibody (Wako Pure Chemical Ind., Osaka). Cells were observed 
under a Nikon fluorescence microscope as previously described [13]. 
2,7. Itaarrrohforrit~g urral)ais 
Total cellular protein of CHO-KI cells and their transformants was 
extraclcd by lysis with the SDS-PAGE sample loading buffer (2% 
SDS, 10% glycerol, 5% 2-mercaptoriiitiuol, 0.02% Bromophenol blue 
and 62,s mM Tris-HCI, pH 6.13). After centrifugation, the cell lysates 
were separated on SDS-polyacrylnmide gel (16%) [14] and blotted 
onto a nitrowllulose filter (Sartorius. Gbttingen) by the electroblot- 
ting method [Is]. The immunoreactive gene products were detected 
with PA-IN and colloidal gold particle-labeled goat anti-mouse IgG 
antibody (AuroProbe BLplus GAM IgG, Amersham). IntenSE BL 
silver enhancement kit (Amersham) was used for intensification of the 
positive bands. 
2.8. High perfortrmcr liquid chrontotogrophy 
The conditioned medium of transformed CHO-KI cells was con- 
centrated with Amprep C2 columns (Amersham) and applied on 
TSKgcl ODS-80TM column (4.6 mm i.d, x IS cm, TOSOH, Tokyo). 
Samples were eluted from the column with a linear 50 min-gradlent 
of acetonitrile (O-50%) containing 0.1% TFA at a flow rate of I.0 
ml/min at room temperature, Fractions (I .O ml each) were collected 
from 30-45 min retention time. 
Collected samples were lyophilized and dissolved in 0.5 ml of 
Hanks’ balanced salt solution (HBSS) and were used for immunoreac- 
tivity and biological activity csls. 
2.9. Derecrion o$ bioiogfcd activity 
CHO-Kl cells and their transformants were seeded into 150.cm’ 
flasks at the density of 4 x 10’ per ml and cultured in normal medium 
for two days alter which serum-free medium was used. This serum-free 
conditioned medium was harvested on the next day and used to ex- 
amine the biologicnl activity of secreted PACAPs. 
PCI2h cells were seeded into a SUMILON collagen-coated 24- well 
plate (Sumitomo Bakelite Co., Tokyo) at the density of 2 x IOQ per 
well. Three days after seeding, eells were washed twice with serum- free 
DMEM, and then I ml of serum-free DMEM containing 50, 25 and 
10% of serum-free conditioned medium of CHO-KI cells or their 
transformants was added to the PCI2h cells. The morphological 
change of the treated cells were observed three days after treatment. 
To examine the CAMP induction, PCl2h cells were xeded in a 
SUMILON wlln~en-coated 48.well plate at the density of 5 x IO gcr 
well and cultured for three days. Cells were washed twice with HBSS. 
and 500 ,uI of sample prepared with RP-HPLC was applied into the 
well. Cells were then incubated for 2 h at 37°C and the conditioned 
media were collected. CAMP secreted into the conditioned media was 
assayed with [‘*QAMP Assay Kit (Amenham). 
3. RESULTS AND DISCUSSION 
3.1. Establishment of the cefi line which expresses 
ir- PA CAP 
In recent years, the cDNAs encoding neuropeptides 
have been cloned and expressed in cultured cells, such 
as neuropeptide Y (NPY) in CHO [ 161, enkephalin in 
BSC-40 cells [ 171, proopiomelanocortin (POMC) in CV- 
1 (green monkey kidney) [18], and somatostatin in 3T3 
cells [19]. We have presently succeeded in establishing 
a novel CHO transformant which produces a large 
amount of ir-PACAP into the culture medium. 
CHO-Kl cells were transfected with the expression 
(Kb) A 0 
. . 
0.24- 
Fig. 2. Northern blot analysis of poly(A)’ RNA extracted from CHO 
cells. (Lane A) CHOtf705.S; (lane B) CHO-ICI. 
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Fig. 3, Immunofluoretient’siaining of PACAP in’ intact cells. CHOU%X.5 and CHO-KI cells were mix-cultured and stained wiih’ mouse 
anti-PACAP monoclonal antibody PA-IN and FITC-conjugated rabbit anti-mouse I&G antibody after fixation (x 280). Arrow indicates a colony 
of CHOt1705.5 cells. 
vector pTS705 containing human PACAP cDNA and 
pSV2neo, and the transformants were selected by G418. 
Of the isolated 22 transformants, 20 transformants were 
revealed to produce ir-PACAP. Especially, clone No. 5 
(named CHOtf705.5) synthesized more than 80 @ml of 
ir-PACAP. The cell number of CHOtt705.5 increased 
until day 3 after seeding and reached a plateau, but 
ir-PACAP production decreased after the peak on day 
3. These facts suggest hat the sequence of the PACAP 
cDNA in pTS705 is functional for translation, although 
it has only one base before the translation initiation 
codon ATG [4], and that PACAP has a very short life- 
time because PACAP has three dibasic pairs of amino 
acid residues, Arg’J5-Lys”6, Ly~‘~~-Lys’~? and Lysloo-- 
Arg’“’ in a molecule and is processed easily by 
proteases. This established cell line was used for further 
experiments. 
A 6 6 (kD) 
To clarify that the production of ir-PACAP by 
CHOtf705.5 was the result of transcription and transla- 
Fig. 4. Immunoblotting analysis of cell extracts. (Lane Af 
CHOtf105.5; (lanc 6) CHO-Kl; (lane C) molecultir weight markers. 
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Fig. 5. Neuritu outgrowth of PCl?h cells after treatment with the serum-free conditioned medium of CHOtl7OS.S (x 180). (A-C) CHOtf705.S 
conditioned medium, 50.25 and lo%, respectively; (D) CHO-KI conditioned medium, 50%. 
tion of inserted human PACAP cDNA, Northern blot- 
ting analysis was performed. The mRNA hybridized to 
the human PACAP cDNA probe was detected in the 
poly(A)+ RNA extracted from CHOtf7OS.S cells but not 
from CHO-K I cells (Fig. 2). The main band of 1.4 kb 
was almost the same size of the cDNA in the expression 
vector pTS705. This fact indicates that the transcription 
of the gene was generated under the control of the SW0 
early promoter. However, the second band of 0.S kb 
remains unknown, 
53 
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Fig. 6. RP-HPLC analysis of the concentrated cultured medium of CHOtflO5.5 cells, 100 ml of the conditioned medium was concentrated and 
applied on RP-HPLC. 
3.3. Molecuh profile of hman ir-PACAP irr trans- 
formed CHO cek 
To determine the localization of the produced 
PACAP in the cells, immunofluorescent staining of 
CHOtE’05.5 and CHO-Kl cells was performed. When 
CHOtf705.5 and CHO-Kl cells were treated with 
mouse anti-PACAP monoclonal antibody PA-IN and 
FITC-conjugated anti-mouse IgG, the fluorescence of 
FITC was detected in the cytoplasm of CHOtf705,S 
cells, but not in the CHO-Kl cells (Fig. 3). This suggests 
that the PACAP precursor was synthesized in the cy 
toplasm of CHOtf705.5 cells and the mature PACAP 
was secreted after processing. 
To determine the molecular size of the PACAP pre- 
cursor in cytoplasm, immunoblotting analysis was per- 
formed. Fig. 4 shows that immunoreactive materials in 
the cell extract of CHOtf105.5 were detected as a main 
band of 21.5 kDa, which was nearly equal to the molec- 
ular weight of prepro-PACAP calculated from the 
amino acid sequence deduced from the nucleotide se- 
quence of human PACAP [5]. 
These results confirmed that we had cloned the 
PACAP cDNA which could reasonably be expressed in 
the CHOtf7 05.5 cells. 
3.4. Neurire exrension with PA CAP 
The PC12h cell is known to respond to nerve growth 
factor, basic fibroblast growth factor (SFGF), sAMP 
and forskolin by the extension of neurites [20,21]. We 
observed that PC 12h cells extended neurites when stim- 
ulated with synthetic PACAP and PACAP (data 
54 
not shown). To know whether the ir-PACAP produced 
by CHOtf705.5 is biologically active, we treated the 
PC 12h cells with the serum-free conditioned medium of 
CHOtf705.5. As expected, neurite outgrowth of PC1 2h 
was observed, and its frequency depended on the con- 
centration of conditioned medium added to PCl2h cells 
(Fig. SA-D). 
3.5. Analysis of ir-PACAP and ir-PRP by RP-HPLC 
As it has been reported that PACAP and 
PACAP activate the adenylate cyclase in PC1211 cells 
[3], the CAMP production in PC12h cells was tested to 
determine the biological activity of molecules in con- 
ditioned medium of CHOtf705.5 separated by RP- 
HPLC. As shown in Fig. 6, the peak of ir-PACAP was 
observed at the retention time of 33-34 and 36-37 min, 
respectively, and that of ir-PRP was detected at the 
retention time of 38-39 min. On the other hand, the 
activity against CAMP production in PCl2h cells gave 
two peaks at the retention times of 34-35 and 37-38 
min. These correspond to the positions where chemi- 
cally synthesized PACAP and PACAP27, respec- 
tively, were eluted. 
From RP-HPLC analysis, the components inducing 
CAMP activity in PC 12h cells could be positioned at the 
same retention time as that of chemically synthesized 
PACAP and PACAP27, and also the peak of ir- 
PACAP was nearly the same as synthesized PACAPs. 
Ir-PRP had a different retention time from that of syn- 
thesized PRP (Asp42-Ala”0) (40- 41 min). As the mole- 
cular profile, especially the biological activity of this PRP 
Volume 298, number 1 FEBS LETTERS F&wy 1992 
H PACAP L 
Fig. 7. Schematic model of processing pathway of PACAP precursor. 
or PRP-containing peptide, has not been fully exam- 
ined, further investigations are currently under way. 
The schematic model of the processing pathway of 
PACAP precursor is proposed in Fig. 7. PACAP and 
PRP are thought to be processed from the same pre- 
cursor. 
Although this PACAP has been isolated by monitor- 
ing the activity of stimulation of adenylate cyclase, and 
the neurite outgrowth of PC12h cells may be the result 
of the CAMP synthesized by the stimulated adenylatc 
cyclase, many other physiological roles of PACAP 
cannot be ignored. Recently it has been reported that 
PACAPs stimulate the production of IL-6 in anterior 
pituitary cells [22] and that they prevent gp120-induced 
neuronal cell death [23]. In addition, it has been 
reported that PACAPs stimulate amylase secretion 
from rat pancreas when injected i.v. [24] It will be in- 
triguing to decipher the multiple in vivo functions of this 
peptide. 
ncksowh~g~rncnu: WC are grateful to Dr. Nobuhiro Suzuki for his 
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